CAPS Key Stats
- CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu Nov 21
- Capstone Therapeutics Announces a LipimetiX Development, LLC Presentation at the American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit of AEM-28 on Established Atherosclerotic Les noodls Nov 19
- Capstone Therapeutics to Hold Quarterly Operating Update Conference Call noodls Nov 12
- CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report Nov 12
- CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu Aug 14
- Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results GlobeNewswire Aug 14
- Q2 2013 Capstone Therapeutics Earnings Release - Time Not Supplied Aug 14
- Capstone Therapeutics to Hold Quarterly Operating Update Conference Call GlobeNewswire Aug 7
- CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 17
- Capstone Therapeutics Corp. Part-Owner Buys 300K Shares and 4 Insider Buys to Note Jun 12
CAPS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Capstone Therapeutics is up 59.45% over the last year vs S&P 500 Total Return up 30.43%, ARCA biopharma down 5.02%, and ACADIA Pharmaceuticals up 424.4%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Balance Sheet View Statement
Pro Ratings for CAPS
Pro Strategies Featuring CAPS
Did Capstone Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Capstone Therapeutics Corp is a biotechnology company developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions.